July 26 (Reuters) - European Medicines Agency:

* EMA SAYS UPDATED ITS GUIDANCE ON APPLYING FOR A ROLLING REVIEW OF A COVID-19 VACCINE OR TREATMENT

* EMA: REVIEW IS REDUCED TO 150 DAYS (FROM 210 DAYS) OR LESS AFTER VALIDATION OF A COMPLETE APPLICATION